NCT06385067View on ClinicalTrials.gov

Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions
Coronary Artery Disease
Interventions
DEVICE

Biolimus Coated Coronary Artery Balloon Dilation Catheter

Patients with Coronary Artery Disease will be treated with Biolimus Coated Coronary Artery Balloon Dilation Catheter

Sponsors
All Listed Sponsors
lead

JW Medical Systems Ltd

INDUSTRY